Search Results

Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells.

• Authors : Pratummanee K; Department of Biochemistry, Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand.; Kerdkumthong K

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/metabolism ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy

• Source: Molecular medicine reports [Mol Med Rep] 2024 Nov; Vol. 30 (5). Date of Electronic Publication: 2024 Sep 06.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Mesenchymal stem cell‑derived exosomes loaded with 5‑Fu against cholangiocarcinoma in vitro .

• Authors : Chen M; Department of Medicine, Graduate School, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.; Li Y

Subjects: Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/drug therapy ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy

• Source: Molecular medicine reports [Mol Med Rep] 2022 Jun; Vol. 25 (6). Date of Electronic Publication: 2022 May 11.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).

• Authors : Yang R; Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R. China.; Song Y

Subjects: Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/genetics ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics

• Source: Molecular medicine reports [Mol Med Rep] 2022 May; Vol. 25 (5). Date of Electronic Publication: 2022 Mar 18.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance.

• Authors : Cao, Jun¹ (AUTHOR); Zhang, Chi² (AUTHOR); Jiang, Guo-Qing² (AUTHOR)

• Source: Molecular Medicine Reports. Aug2019, Vol. 20 Issue 2, p1915-1924. 10p.

Record details

Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data.

• Authors : Zhong, Wei¹; Dai, Lianzhi²; Liu, Jing¹

• Source: Molecular Medicine Reports. Apr2018, Vol. 17 Issue 4, p5744-5753. 10p. 1 Color Photograph, 3 Diagrams, 2 Charts, 2 Graphs.

Record details

Phenformin inhibits cell proliferation and induces cell apoptosis and autophagy in cholangiocarcinoma.

• Authors : Hu, Shuyang¹; Ouyang, Qing¹; Cheng, Qingbao¹

• Source: Molecular Medicine Reports. Apr2018, Vol. 17 Issue 4, p6028-6032. 5p. 1 Chart, 3 Graphs.

Record details

GSK‑3β inhibition promotes doxorubicin‑induced apoptosis in human cholangiocarcinoma cells via FAK/AKT inhibition.

• Authors : Li L; Department of Biochemistry and Molecular Biology, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.; Xiang Y

Subjects: Bile Duct Neoplasms/Bile Duct Neoplasms/Bile Duct Neoplasms/*metabolism ; Cholangiocarcinoma/Cholangiocarcinoma/Cholangiocarcinoma/*metabolism ; Doxorubicin/Doxorubicin/Doxorubicin/*pharmacology

• Source: Molecular medicine reports [Mol Med Rep] 2020 Nov; Vol. 22 (5), pp. 4432-4441. Date of Electronic Publication: 2020 Sep 10.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma.

• Authors : GUANGHUA YANG^1,2; HUAJIE ZONG¹

• Source: Molecular Medicine Reports. 2016, Vol. 13 Issue 6, p4786-4790. 5p.

Record details

Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal-regulated kinase signaling pathway.

• Authors : VANICHAPOL, THITINEE¹; LEELAWAT, KAWIN² ; HONGENG, SURADEJ³

• Source: Molecular Medicine Reports. 2015, Vol. 12 Issue 3, p3265-3272. 8p.

Record details

Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.

• Authors : YAQING CHEN¹; DAN LIU² ; PENGFEI LIU³

• Source: Molecular Medicine Reports. Mar2017, Vol. 15 Issue 3, p1051-1056. 6p.

Record details